Rac family small GTPase 1 pseudogene 7 (RAC1P7)

Rac family small GTPase 1 pseudogene 7 (RAC1P7) is classified as a **pseudogene** of the RAC1 gene[1]. Unlike typical protein-coding genes, pseudogenes like RAC1P7 generally *do not encode functional proteins* due to mutations or truncations that prevent translation of a full-length functional protein. RAC1P7 shares significant sequence similarity with the coding RAC1 gene but contains mutations rendering it non-coding; only a short peptide, if any, could be translated[2]. Functional studies specific to RAC1P7 are very limited. Some evidence from related rac1 pseudogenes suggests that such pseudogenes may have regulatory RNA functions, such as acting as *competing endogenous RNA* (ceRNA) or miRNA decoys, potentially influencing the expression of their parental genes or participating in gene regulatory networks[5][3]. Overexpression of a rac1 pseudogene (likely RAC1P7) has been observed in various brain tumors, suggesting a possible role in tumorigenesis, but these mechanisms remain speculative[2]. **RAC1P7 is not considered a therapeutic or pharmacological target** (e.g., not an enzyme, receptor, transporter, or transcription factor), and there are no drugs that directly act on this pseudogene, nor mechanisms of action or biomarker status associated with it. It may sometimes appear in transcriptomic screens as differentially expressed in disease, but this is not an indication of therapeutic tractability[2][1]. Because RAC1P7 is a pseudogene and not a functional receptor, enzyme, or other classical therapeutic target, it should be flagged as *not a target* with *incorrect/irrelevant* for standard drug discovery applications.

Other names

ras-related C3 botulinum toxin substrate 1 pseudogene 7RAC1P7